Literature DB >> 15741307

Association of a genetic polymorphism of the E-cadherin gene with prostate cancer in a Japanese population.

Toshiyuki Kamoto1, Yoshiaki Isogawa, Yousuke Shimizu, Sachiko Minamiguchi, Hidefumi Kinoshita, Yoshiyuki Kakehi, Kenji Mitsumori, Shingo Yamamoto, Tomonori Habuchi, Tetsuro Kato, Osamu Ogawa.   

Abstract

The E-cadherin gene has been identified as having a physiological role in cellular attachment, and is hypothesized to participate in carcinogenesis. A polymorphism (an A to C substitution) in the 5'-untranslated region has a direct effect on E-cadherin gene transcriptional regulation. We explored the association between E-cadherin gene polymorphism and the risk of prostate cancer in a Japanese population. The subjects consisted of 236 patients with prostate cancer, 209 benign prostatic hyperplasia (BPH) patients and 139 male controls. A marginally significant difference was found between prostate cancer patients and male controls (P = 0.053). No significant difference was observed between prostate cancer and BPH patients. When patients with prostate cancer were divided into two groups, stage A+B and stage C+D, a significant difference was observed between progressive cancer patients (stage C+D) and male controls (odds ratio = 1.93, P = 0.016). It is possible that the presence of one A allele resulted in an increased risk of cancer progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741307     DOI: 10.1093/jjco/hyi040

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.

Authors:  Zheng Chang; Hongbing Zhou; Yi Liu
Journal:  Tumour Biol       Date:  2014-07-24

2.  The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.

Authors:  Li-Xin Qiu; Ru-Tian Li; Jian-Bing Zhang; Wen-Zhao Zhong; Jian-Ling Bai; Bao-Rui Liu; Ming-Hua Zheng; Xiao-Ping Qian
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

3.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

4.  Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.

Authors:  Lin Wang; Guiying Wang; Chenqi Lu; Bo Feng; Jiuhong Kang
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

Review 5.  Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.

Authors:  Rufus Cartwright; Altaf Mangera; Kari A O Tikkinen; Prabhakar Rajan; Jori Pesonen; Anna C Kirby; Ganesh Thiagamoorthy; Chris Ambrose; Juan Gonzalez-Maffe; Phillip R Bennett; Tom Palmer; Andrew Walley; Marjo-Riitta Järvelin; Vik Khullar; Chris Chapple
Journal:  Eur Urol       Date:  2014-01-22       Impact factor: 20.096

Review 6.  Regulatory Variants and Disease: The E-Cadherin -160C/A SNP as an Example.

Authors:  Gongcheng Li; Tiejun Pan; Dan Guo; Long-Cheng Li
Journal:  Mol Biol Int       Date:  2014-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.